ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664161; 2) Community: the network communities that were significantly associated with the response to NSC 664161; 3) Molecule: the relationships between components within communities and NSC 664161; 4) MDR: the compounds that were significantly associated with the NSC 664161.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0105244982742819 0.44883875
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0105244982742819 0.56626377
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0105244982742819 0.060018752
NSC 328410 Camptothecin Derivative 0.0105244982742819 0.21039704
NSC 603071 Aminocamptothecin 0.0105244982742819 0.084074469
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0105244982742819 0.23300311
NSC 606499 Camptothecin Derivative 0.0105244982742819 0.12443074
NSC 673652 2-Ethylaminoestradiol 0.0105244982742821 -0.15501949
NSC 681641 Camptothecin Derivative 0.0105244982742821 0.033817034
NSC 697286 LY 294002 0.0105244982742821 0.062369463
Total:48  Current:11    [First] [Prev] [Next] [Last]